NEAT1 and non-small cell lung carcinoma: The correction was independent from other clinical covariates, revealing that NEAT1 expression levels could be as a useful prognostic biomarker to help identify patients who are at a higher risk of NSCLC progression, which were in accordance with Pan and his colleagues’ findings [66].